Search

everythinglearnresearchcommunity

for

Search:↓

Epidermal stem cells help heal severe skin wounds and have potential for medical treatments.

New genetic locations explain much of hair color variation in Europeans.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

The study created hair-bearing skin models that lack a key protein for skin layer attachment, limiting their use for certain skin disease research.

Alopecia areata greatly affects people's life quality, mental health, and work life.

JAK inhibitors offer new hope for treating severe alopecia areata.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Platelet-rich plasma may improve wound healing by stimulating cell growth and blood vessel formation.

People often have iron deficiency after weight-loss surgery, which can cause symptoms like hair loss and dizziness, and iron levels should be tested to diagnose it.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

The document concludes that improving patient safety and quality is increasingly important in dermatology.

Vegetable oils rich in antioxidants may help prevent skin aging caused by free radicals.